Development Center for Biotechnology
The Development Center for Biotechnology (DCB) is Taiwan's pioneering biotech research organization established in 1984, dedicated to advancing biotechnological research, drug development, and industry collaboration. With a mission to improve quality of life, DCB focuses on innovative research, technology transfer, and fostering industry-academic partnerships to promote the growth of Taiwan's biotech sector.
Industries
Nr. of Employees
large (251-1000)
Development Center for Biotechnology
Products
CHO-based high-yield expression system (CHO-C)
A CHO host and expression system comprising host cells, proprietary vectors and culture components designed for high-yield recombinant protein expression; available via licensing or contract development.
Bispecific antibody technology platform
A platform for designing and producing bispecific antibody formats optimized for stability, yield and dual-function mechanisms such as T‑cell engagement.
LNP nucleic acid formulation platform
Formulation capabilities and analytical workflows for lipid nanoparticle delivery of nucleic acid therapeutics, including particle manufacture and characterization.
CHO-based high-yield expression system (CHO-C)
A CHO host and expression system comprising host cells, proprietary vectors and culture components designed for high-yield recombinant protein expression; available via licensing or contract development.
Bispecific antibody technology platform
A platform for designing and producing bispecific antibody formats optimized for stability, yield and dual-function mechanisms such as T‑cell engagement.
LNP nucleic acid formulation platform
Formulation capabilities and analytical workflows for lipid nanoparticle delivery of nucleic acid therapeutics, including particle manufacture and characterization.
Services
Protein biologics R&D services
End-to-end support for biologic drug discovery and development including antibody screening, optimization, characterization, and early process development.
Small-molecule R&D services
Research support for chemical drug discovery and preclinical development activities.
Integrated drug development value‑added services
Project integration services that combine discovery, development, regulatory support and commercialization planning to accelerate product translation.
LNP formulation and analytical testing
Formulation development and testing services for lipid-nanoparticle based nucleic acid therapeutics including particle characterization and performance assays.
GLP-compliant preclinical and clinical sample testing
GLP-audited laboratory testing for preclinical studies and clinical sample analysis, including biosafety assessments.
cGMP pilot manufacturing and CMO facilitation
Pilot-scale cGMP manufacturing capacity and facilitation of investment and commercialization for pilot plant operations producing clinical trial materials.
Protein biologics R&D services
End-to-end support for biologic drug discovery and development including antibody screening, optimization, characterization, and early process development.
Small-molecule R&D services
Research support for chemical drug discovery and preclinical development activities.
Integrated drug development value‑added services
Project integration services that combine discovery, development, regulatory support and commercialization planning to accelerate product translation.
LNP formulation and analytical testing
Formulation development and testing services for lipid-nanoparticle based nucleic acid therapeutics including particle characterization and performance assays.
GLP-compliant preclinical and clinical sample testing
GLP-audited laboratory testing for preclinical studies and clinical sample analysis, including biosafety assessments.
cGMP pilot manufacturing and CMO facilitation
Pilot-scale cGMP manufacturing capacity and facilitation of investment and commercialization for pilot plant operations producing clinical trial materials.
Expertise Areas
- Protein biologics development
- Antibody engineering and bispecific antibodies
- Mammalian cell line and expression system development
- Preclinical testing and GLP bioassays
Key Technologies
- Bispecific antibody engineering
- CHO cell line development
- High‑yield mammalian expression systems
- Upstream/downstream process development for biologics